MyFinsight
Home
Blog
About
Proceeds from maturities
and redemptions of...
$48,000K
(-5.88%↓ Y/Y)
Proceeds from stock
option exercises and...
$2,424K
Net cash (used in)
provided by investing...
$26,933K
(115.57%↑ Y/Y)
Net cash provided by
financing activities
$1,801K
(-99.15%↓ Y/Y)
Canceled cashflow
$21,067K
Canceled cashflow
$623K
Net increase in
cash, cash...
$14,112K
(203.94%↑ Y/Y)
Canceled cashflow
$14,622K
Purchases of long-term
investments
$20,028K
(-35.54%↓ Y/Y)
Purchases of property and
equipment
$1,039K
(-50.80%↓ Y/Y)
Stock-based compensation
expense
$7,016K
(-7.72%↓ Y/Y)
Accounts payable
$2,862K
(507.64%↑ Y/Y)
Depreciation expense
$709K
(9.08%↑ Y/Y)
Prepaid expenses and
other current assets
-$415K
(-111.51%↓ Y/Y)
Amortization of operating
lease right-of-use...
$409K
(-32.62%↓ Y/Y)
Deferred revenue
$280K
(-72.33%↓ Y/Y)
Amortization of premium
(discount) on short-term...
$95K
Other long-term
liabilities
$71K
(-92.98%↓ Y/Y)
Other long-term
assets
-$40K
(-566.67%↓ Y/Y)
Net provision
(recovery) for excess and...
$23K
(-87.83%↓ Y/Y)
Provision for expected
credit losses
$16K
something is missing
-$623K
Net cash used in
operating activities
-$14,622K
(56.44%↑ Y/Y)
Canceled cashflow
$11,936K
Net loss
-$23,403K
(48.59%↑ Y/Y)
Accounts receivable
$2,319K
(485.86%↑ Y/Y)
Operating lease liability
-$400K
(29.45%↑ Y/Y)
Accrued expenses and
other current...
-$222K
(91.29%↑ Y/Y)
Inventories
$214K
(-95.08%↓ Y/Y)
Back
Back
Cash Flow
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)
source: myfinsight.com